Haemalogix
0 followers
‌
Haemalogix focuses on the development and commercialization of novel immuno-oncology and immune-therapies.
Industries
+1
Headquarters
Employees
Links
Org chart
Bryce Carmine
Chairman & CEO
Bryce Carmine
Collapse
Rosanne Dunn
Chief Scientific Officer & Director
Tertia Dex
Chief Manufacturing & Development Officer
Mohamad Hussein
Chief Medical Advisor
Rhonda Oshanek
Senior Medical Writer
Laurence Turka
Board Of Directors
Damian Clarke-Bruce
CEO & Managing Director
